{
     "PMID": "9690071",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19980922",
     "LR": "20131121",
     "IS": "0869-2092 (Print) 0869-2092 (Linking)",
     "VI": "61",
     "IP": "3",
     "DP": "1998 May-Jun",
     "TI": "[The effect of carbamazepine on the content of monoamines and their metabolites in the brain structures of rats with audiogenic epilepsy].",
     "PG": "25-7",
     "AB": "It was shown that the content of serotonin (5-OT) and 5-oxyindoleacetic acid (5-OIAA) in the temporal cortex, hippocampus and medulla oblongata and the content of dopamine and 3,4-dihydroxyphenilacetic acid in the striatum are increased initially, while the level of norepinephrine in the striatum is reduced in Krushinskii-Molodkina rats genetically predisposed to audiogenic epilepsy in comparison with Wistar rats. Carbamazepine levelled out the changes in the 5-OT and 5-OIAA levels at the peak of the audiogenic attack in the temporal cortex and hippocampus, causing at the same time a sum increase in the content of all monoamines and their metabolites in the medulla oblongata and striatum.",
     "FAU": [
          "Kosacheva, E S",
          "Kudrin, V S",
          "Fedotova, I B",
          "Semiokhina, A F",
          "Raevskii, K S"
     ],
     "AU": [
          "Kosacheva ES",
          "Kudrin VS",
          "Fedotova IB",
          "Semiokhina AF",
          "Raevskii KS"
     ],
     "AD": "Laboratory of Neurochemical Pharmacology, Russian Academy of Medical Sciences, Moscow, Russia.",
     "LA": [
          "rus"
     ],
     "PT": [
          "Comparative Study",
          "English Abstract",
          "Journal Article"
     ],
     "TT": "Vliianie karbamazepina na soderzhanie monoaminov i ikh metabolitov v strukturakh mozga krys s audiogennoi epilepsiei.",
     "PL": "Russia (Federation)",
     "TA": "Eksp Klin Farmakol",
     "JT": "Eksperimental'naia i klinicheskaia farmakologiia",
     "JID": "9215981",
     "RN": [
          "0 (Anticonvulsants)",
          "0 (Biogenic Monoamines)",
          "33CM23913M (Carbamazepine)"
     ],
     "SB": "IM",
     "MH": [
          "Acoustic Stimulation",
          "Animals",
          "Anticonvulsants/*pharmacology",
          "Biogenic Monoamines/*metabolism",
          "Brain/*drug effects/metabolism",
          "Brain Chemistry/drug effects",
          "Carbamazepine/*pharmacology",
          "Dose-Response Relationship, Drug",
          "Epilepsy/metabolism",
          "Male",
          "Rats",
          "Rats, Inbred Strains",
          "Rats, Wistar",
          "Seizures/*metabolism"
     ],
     "EDAT": "1998/08/05 00:00",
     "MHDA": "1998/08/05 00:01",
     "CRDT": [
          "1998/08/05 00:00"
     ],
     "PHST": [
          "1998/08/05 00:00 [pubmed]",
          "1998/08/05 00:01 [medline]",
          "1998/08/05 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Eksp Klin Farmakol. 1998 May-Jun;61(3):25-7.",
     "term": "hippocampus"
}